Fri, Dec 26, 2014, 1:55 PM EST - U.S. Markets close in 2 hrs 5 mins

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • stocklooking stocklooking Apr 12, 2013 2:48 AM Flag

    What were they doing these years?

    With 245 employees, a great platform, our own products are mostly in phase I or preclinical. In the mean time, TDM1 has already been approved. All are standing over there watching or lending hands to genetech scientists?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Good question, many of us have been asking the same for the past year. I think 901 is older then T-DM1. I don't expect anything from 901, I think North will go South, but...if just one of the early stage, wholly owned drugs hits the mark (+ T-DM1 does $BB's), IMGN is cheap, if 2 hit, it's a triple even from here and if more than 2 hit IMGN could do what REGN did, CELG and many other big winners. We should learn more today.

 
IMGN
5.89-0.01(-0.17%)1:55 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.